Inhibition of C6 glioma in vivo by combination chemotherapy of implantation of polymer wafer and intracarotid perfusion of transferrin-decorated nanoparticles

Oncology Reports

Volumn 27, Issue 1, 2012, Pages 121-128

  Han, Lei ^a,b   Ren, Yu ^a   Long, Lixia ^c   Zhong, Yue ^a,b   Shen, Changhong ^a,b   Pu, Peiyu ^a,b   Yuan, Xubo ^c   Kang, Chunsheng ^a,b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c TIANJIN UNIVERSITY   (China)

Author keywords

BCNU; Glioma; Nanoparticles; Poly(D,L lactic acid); Transferrin; Wafer

Indexed keywords

CARMUSTINE; POLYGLACTIN; TRANSFERRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; COLORIMETRY; CONTROLLED STUDY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG IMPLANTATION; DRUG RELEASE; GLIOMA; IN VITRO STUDY; IN VIVO STUDY; MALE; NANOEMULSION; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL TIME; X RAY PHOTOELECTRON SPECTROSCOPY; ZETA POTENTIAL;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARMUSTINE; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; GLIOMA; INFUSIONS, INTRA-ARTERIAL; MALE; MICROSPHERES; NANOPARTICLES; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; TRANSFERRIN;

EID: 84855260090     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1459     Document Type: Article

References (44)

1. Jiang G, Wei ZP, Pei DS, Xin Y, Liu YQ and Zheng JN: A novel approach to overcome temozolomide resistance in glioma and melanoma: inactivation of MGMT by gene therapy. Biochem Biophys Res Commun 406: 311-314, 2011.
2. Quick A, Patel D, Hadziahmetovic M, Chakravarti A and Mehta M: Current therapeutic paradigms in glioblastoma. Rev Recent Clin Trials 5: 14-27, 2010.
3. Harn HJ, Lin SZ, Lin PC, Liu CY, Liu PY, Chang LF, Yen SY, Hsieh DK, Liu FC, Tai DF and Chiou TW: Local interstitial delivery of z-butylidenephthalide by polymer wafers against malignant human gliomas. Neuro Oncol 13: 635-648, 2011.
4. Wang X, Duan X, Yang G, Zhang X, Deng L, Zheng H, Deng C, Wen J, Wang N, Peng C, Zhao X, Wei Y and Chen L: Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model. PLoS One 6: e18490, 2011.
5. Reese TS and Karnovsky MJ: Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol 34: 207-217, 1967.
6. Lesniak MS, Upadhyay U, Goodwin R, Tyler B and Brem H: Local delivery of doxorubicin for the treatment of malignant brain tumors in rats. Anticancer Res 25: 3825-3831, 2005. (Pubitemid 41665151)
7. Nakabayashi H, Sakaguchi M, Katsuyama J and Hakuba A: Proliferative potential of meningiomas evaluated by proliferating cell nuclear antigen expression. J Neurooncol 24: 209-217, 1995.
8. DiMeco F, Li KW, Tyler BM, Wolf AS, Brem H and Olivi A: Local delivery of mitoxantrone for the treatment of malignant brain tumors in rats. J Neurosurg 97: 1173-1178, 2002. (Pubitemid 35253555)
9. Menei P, Venier MC, Gamelin E, Saint-André JP, Hayek G, Jadaud E, Fournier D, Mercier P, Guy G and Benoit JP: Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma: a pilot study. Cancer 86: 325-330, 1999. (Pubitemid 29327590)
10. Westphal M, Ram Z, Riddle V, Hilt D and Bortey E: Executive Committee of the Gliadel Study Group. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Acta Neurochir (Wien) 148: 269-275, 2006. (Pubitemid 43341024)
11. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M, Brem S and Mohr G: Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet 345: 1008-1012, 1995.
12. Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, Whittle IR, Jääskeläinen J and Ram Z: A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 5: 79-88, 2003. (Pubitemid 36422560)
13. Pardridge WM: Non-invasive drug delivery to the human brain using endogenous blood-brain barrier transport systems. Pharm Sci Technolo Today 2: 49-59, 1999.
14. Balossier A, Dörner L, Emery E, Heese O, Mehdorn HM, Menei P and Singh J: Incorporating BCNU wafers into malignant glioma treatment: European case studies. Clin Drug Investig 30: 195-204, 2010.
15. Ogris M, Brunner S, Schüller S, Kircheis R and Wagner E: PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther 6: 595-605, 1999. (Pubitemid 29192668)
16. Béduneau A, Saulnier P and Benoit JP: Active targeting of brain tumors using nanocarriers. Biomaterials 28: 4947-4967, 2007. (Pubitemid 47362345)
17. Han L, Zhang AL, Wang HJ, Pu PY, Kang CS and Chang J: Tat-BMPs-PAMAM conjugates enhance therapeutic effect of small interference RNA on U251 glioma cells in vitro and in vivo. Hum Gene Ther 21: 417-426, 2010.
18. Tang R, Ji W, Panus D, Palumbo RN and Wang C: Block copolymer micelles with acid-labile ortho ester side-chains: synthesis, characterization, and enhanced drug delivery to human glioma cells. J Control Release 151: 18-27, 2011.
19. Han L, Zhang A, Wang H, Pu P, Kang C and Chang J: Construction of novel brain-targeting gene delivery system by natural magnetic nanoparticles. J Appl Pol Sci 121: 3446-3454, 2011.
20. Pardridge WM: Preparation of Trojan horse liposomes (THLs) for gene transfer across the blood-brain barrier. Cold Spring Harb Protoc 2010: pdb.prot5407, 2010.
21. Cinti C, Taranta M, Naldi I and Grimaldi S: Newly engineered magnetic erythrocytes for sustained and targeted delivery of anti-cancer therapeutic compounds. PLoS One 6: e17132, 2011.
22. Kang C, Yuan X, Zhong Y, Pu P, Guo Y, Albadany A, Yu S, Zhang Z, Li Y, Chang J and Sheng J: Growth inhibition against intracranial C6 glioma cells by stereotactic delivery of BCNU by controlled release from poly(D,L-lactic acid) nanoparticles. Technol Cancer Res Treat 8: 61-70, 2009.
23. Loo TL and Dion RL: Colorimetric method for the determination of 1,3-bis(2-chloroethyl)-1-nitrosourea. J Pharm Sci 54: 809-810, 1965.
24. Xu D, Jia Q, Li Y, Kang C and Pu P: Effects of Gamma Knife surgery on C6 glioma in combination with adenoviral p53 in vitro and in vivo. J Neurosurg 105 (Suppl): 208-213, 2006.
25. Yuan, XB, Li H and Yuan YB: Preparation of cholesterol-modified chitosan self-aggregated nanoparticles for delivery of drugs to ocular surface. Carbohyd Polym 65: 337-345, 2006. (Pubitemid 44160627)
26. Limentani SA, Asher A, Heafner M, Kim JW and Fraser R: A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme. J Neurooncol 3: 241-244, 2005. (Pubitemid 40867407)
27. Kircheis R, Wightman L, Schreiber A, Robitza B, Rössler V, Kursa M and Wagner E: Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther 8: 28-40, 2001. (Pubitemid 32162413)
28. Passarella RJ, Spratt DE, van der Ende AE, Phillips JG, Wu H, Sathiyakumar V, Zhou L, Hallahan DE, Harth E and Diaz R: Targeted nanoparticles that deliver a sustained, specific release of Paclitaxel to irradiated tumors. Cancer Res 70: 4550-4559, 2010.
29. Ding H, Inoue S, Ljubimov AV, Patil R, Portilla-Arias J, Hu J, Konda B, Wawrowsky KA, Fujita M, Karabalin N, Sasaki T, Black KL, Holler E and Ljubimova JY: Inhibition of brain tumor growth by intravenous poly (β-L-malic acid) nanobioconjugate with pH-dependent drug release. Proc Natl Acad Sci USA 107: 18143-18148, 2010.
30. Xin H, Jiang X, Gu J, Sha X, Chen L, Law K, Chen Y, Wang X, Jiang Y and Fang X: Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Biomaterials 32: 4293-4305, 2011.
31. Ren WH, Chang J, Yan CH, Qian XM, Long LX, He B, Yuan XB, Kang CS, Betbeder D, Sheng J and Pu PY: Development of transferrin functionalized poly(ethylene glycol)/poly(lactic acid) amphiphilic block copolymeric micelles as a potential delivery system targeting brain glioma. J Mater Sci Mater Med 21: 2673-2681, 2010.
32. Waite CL and Roth CM: PAMAM-RGD conjugates enhance siRNA delivery through a multicellular spheroid model of malignant glioma. Bioconjug Chem 20: 1908-1916, 2009.
33. Kang C, Yuan X, Li F, Pu P, Yu S, Shen C, Zhang Z and Zhang Y: Evaluation of folate-PAMAM for the delivery of antisense oligonucleotides to rat C6 glioma cells in vitro and in vivo. J Biomed Mater Res 93: 585-594, 2010.
34. Li Y, Ogris M, Wagner E, Pelisek J and Rüffer M: Nanoparticles bearing polyethyleneglycol-coupled transferrin as gene carriers: preparation and in vitro evaluation. Int J Pharm 259: 93-101, 2003. (Pubitemid 36638557)
35. Soni V, Kohli DV and Jain SK: Transferrin coupled liposomes as drug delivery carriers for brain targeting of 5-florouracil. J Drug Target 13: 245-250, 2005. (Pubitemid 41086289)
36. Eavarone DA, Yu X and Bellamkonda RV: Targeted drug delivery to C6 glioma by transferrin-coupled liposomes. J Biomed Mater Res 51: 10-14, 2000. (Pubitemid 30331976)
37. Hatakeyama H, Akita H, Maruyama K, Suhara T and Harashima H: Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo. Int J Pharm 281: 25-33, 2004. (Pubitemid 39024260)
38. Madhavan Nampoothiri K, Nair NR and John RP: An overview of the recent developments in polylactide (PLA) research. Bioresour Technol 101: 8493-8501, 2010.
39. Boury F, Ivanova T, Panaieotov I, Proust JE, Bois A and Richou J: Dilatational properties of adsorbed poly (D,L-lactide) and bovine serum albumin monolayers at the dichloromethane/ water interface. Langmuir 11: 1636-1644, 1995.
40. Boury F, Marchais H, Benoit JP and Proust JE: Surface characterization of poly(alpha-hydroxy acid) microspheres prepared by a solvent evaporation/extraction process. Biomaterials 18: 125-136, 1997. (Pubitemid 27033946)
41. Verrecchia T, Huve P, Bazile D, Veillard M, Spenlehauer G and Couvreur P: Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process. J Biomed Mater Res 27: 1019-1028, 1993. (Pubitemid 23206717)
42. Lockman PR, Koziara JM, Mumper RJ and Allen DD: Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J Drug Target 12: 635-641, 2004. (Pubitemid 40100711)
43. Stewart DJ: A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors. J Neurooncol 20: 121-139, 1994.
44. van den Bent MJ: The role of chemotherapy in brain metastases. Eur J Cancer 39: 2114-2120, 2003.